Clik here to view.
Smile Doctors和Dental Monitoring扩大并加快合作，在紧急状态期间向所有患者提供远程监测
巴黎 (美国商业资讯)– Smile Doctors是总部位于美国的最大的正畸DSO（牙科支持组织），在17个州设有220多家诊所，该公司已与Dental...
View ArticleClik here to view.
住友重机械工业株式会社获得在日本生产和销售基于加速器的BNCT系统和照射剂量计算程序的医疗器械审批许可
东京 (美国商业资讯)–住友重机械工业株式会社(Sumitomo Heavy Industries, Ltd., TOKYO:6302)（总经理：下村真司，以下简称“SHI”）与STELLA PHARMA...
View ArticleClik here to view.
Clik here to view.
Samsung Bioepis Announces FDA Approval of 420 mg Multi-dose Vial of...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved a 420 mg multi-dose vial of ONTRUZANT® (trastuzumab-dttb), a biosimilar...
View ArticleClik here to view.
IASO Biotherapeutics Raises $60 Million in Series B Financing Led by GL...
NANJING, China IASO Biotherapeutics (IASO BIO) today announced the completion of $60 million in series B financing led by GL Ventures, which is a venture capital fund of Hillhouse Capital focusing...
View ArticleClik here to view.
Laekna Acquires Exclusive Global Rights to Clinical-Stage Cancer Asset
SHANGHAI Laekna Therapeutics Shanghai Co., Ltd. (Laekna) today announced a new agreement with Novartis giving the China-based biotech company exclusive global rights to Novartis’ anti-PD-L1 Antibody...
View ArticleClik here to view.
三叶草与Dynavax合作评估新型冠状病毒候选疫苗与CpG 1018佐剂的联用
美国加州爱莫利维尔、中国成都 (美国商业资讯)–今天，三叶草生物制药有限公司（以下简称“三叶草生物”）宣布将与美国Dynavax Technologies Corporation公司（纳斯达克代码：DVAX）开展研发合作，推动其基于蛋白的新型冠状病毒候选疫苗“COVID-19 S-三聚体”的研究开发。Dynavax将为三叶草生物提供其专有的Toll样受体 9 （TLR9） 激动剂 的CpG...
View ArticleClik here to view.
Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to...
EMERYVILLE, Calif. & CHENGDU, China Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, and Clover...
View ArticleClik here to view.
基因组学公司路胜生物开发用于新冠病毒诊断和监测的采样器
新加坡 (美国商业资讯)–分子诊断公司路胜生物(Lucence)今天宣布成功开发了SAFER-Sample（Stabilization of nucleic Acid Formulation for Evaluation of RNA，用于评估RNA的核酸制剂稳定性）试剂盒，该试剂盒是一款旨在提高病毒（例如新冠病毒COVID19）感染检测可及性的采样医疗器械。...
View ArticleClik here to view.
NTHU’s Boron Neutron Capture Therapy Center Begins Treating Overseas Brain...
HSINCHU, Taiwan On February 14th the melodious strains of the fourth movement of Mahler’s Fifth Symphony were heard inside the building of Tsing Hua Open pool Reactor (THOR) at National Tsing Hua...
View ArticleClik here to view.
SmileMate Virtual Consultationを5月31日まで無償提供
パリ （ビジネスワイヤ） — デンタル・モニタリングは先週、当社の遠隔歯科ソリューションの簡素化版となるSmileMate Virtual Consultation（スマイルメイト・バーチャル・コンサルテーション）を投入しました。これにより歯科専門家はHIPAAに準拠した方法で遠隔から新規患者の問診を行うことができます。...
View ArticleClik here to view.
SmileMate虚拟看诊—— 5月31日前免费
巴黎 –(美国商业资讯)–Dental Monitoring上周宣布推出其远程牙科解决方案——简化版SmileMate虚拟看诊(SmileMate Virtual Consultation)，使牙科专业人士能以符合《健康保险流通与责任法案》(HIPAA)要求的方式远程评估其新患者的问询。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
ENHERTU® Approved in Japan for Treatment of Patients with HER2 Positive...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the approval of ENHERTU® (trastuzumab deruxtecan), a HER2 directed antibody...
View ArticleClik here to view.
CG Oncology Announces License and Commercialization Agreement with Kissei...
IRVINE, Calif. CG Oncology, Inc. has announced today an exclusive license, development and commercialization agreement with Kissei Pharmaceutical Co., Ltd. (“Kissei”) for its oncolytic immunotherapy...
View ArticleClik here to view.
Ubiquitome’s COVID-19 Fast Test Device in Spotlight
AUCKLAND, New Zealand Ubiquitome’s ability to deliver fast test results for COVID-19 is attracting global inquires and top talent keen to get it to countries in desperate need. Dr Paul Pickering,...
View ArticleClik here to view.
Aroa Biosurgery Opens New Pathway for Advanced Wound Treatment Amidst...
SAN DIEGO Soft tissue repair company Aroa Biosurgery is stepping up to support clinicians and their patients who are battling to treat wounds amid disruption to many existing U.S. facilities for...
View ArticleClik here to view.
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) in...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products...
View ArticleClik here to view.
武田薬品：エグゼクティブ報酬返還ポリシー（クローバックポリシー）の導入について
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社 (東証:4502) (NYSE:TAK)：...
View ArticleClik here to view.
Takeda Adopts Executive Compensation Recoupment Policy
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today announced that its Board of Directors approved an executive compensation recoupment policy (“clawback...
View ArticleClik here to view.
Notice Regarding Business Alliance Between Sanbio and Ocumension in the...
TOKYO SanBio Co., Ltd. (Keita Mori, Representative Director and President, hereinafter “SanBio”) (TOKYO:4592) hereby announces that SanBio has entered into a business alliance with Ocumension (Hong...
View Article